Gardasil

Gardasil Vaccine: Would you take the risk? Why aren’t many receiving Gardasil June 8th, 2006, the FDA approves the Gardasil shot for preventing cervical cancer and/or HPV diseases. The Gardasil shot for best effects is given to both genders between age 11 and 12. The shot is given in 3 doses, the 2nd is given 2 months after the first, while the 3rd is 4 months after the 2nd. Go and receive your vaccine today to protect you from the most common cervical cancer strains! But wait! Only 60% of

parents worry about the safety of Gardasil because it has only been on the market for 9 years. Gardasil has proven effective for 29,000 males and females aged 9-45 in 7 phase 3 trials. Gardasil was safety tested for 5 years before it hit the market in 2006(Vichnin et al. 2015). Worldwide there has been over 178 million doses administered. In 2009, the FDA approved the drug for treatment in boys aged 9-26 for treatment of genital warts (Vichnin et al. 2015). Gardasil studies have looked at the relationship

Gardasil Lobbying Case Merck’s aggressive lobbying campaign was intended to boost sales of its Gardasil vaccine, which received Food and Drug Administration approval. FDA approved Gardasil on June 8, 2006, for females ages 9 -26 to help prevent cervical, vulvar and vaginal cancers caused by Human Papillomavirus (HPV). It included types 16 and 18 and genital warts caused by HPV types 6 and 11 (Bethel University, 2011). The FDA gave Gardasil a fast approval, something called a “Fast Track”. This

it is urgent to decrease the rate of cervical cancer at women. A three-shot Gardasil series vaccine approved by the FDA for girls started to prevent cervical cancer in 2006. There are more than forty types of HPVs and the majority

another every day and they don 't even know it’s happening. There is a vaccination called Gardasil that can prevent HPV for teenage girl, woman and teenage males now. Gardasil should be mandated for parents for vaccinating their children for these viruses. “For all ages between 9-26 years, this vaccination is the best method to prevent HPV infection and the risk of HPV related diseases” (CDC 2014). Gardasil should be a required immunization for getting into middle school or high school requirements

their children since animals are involved in the research and development of several vaccines, including the HPV vaccine. Individuals against animal testing, or recombinant DNA technology (Gardasil (Human Papillomavirus Vaccine) Questions and Answers, 2006) could feel uneasy about the Gardasil vaccine as well (Gardasil 9, 2014). In addition, some fear that this policy will “promot[e] promiscuity” (Marsa,

Introduction, Background & Significance It is estimated that 79 million Americans are currently infected with a strand of Human Papillomavirus (HPV), and that 14 million Americans become infected annually (CDC HPV Questions and Answers, 2016). Human Papillomavirus can cause penile cancer in men, cancer of the vulva, vagina or cervix in females, and esophageal, oropharyngeal, and anal cancers in both men and women (CDC HPV Questions and Answers, 2016). Consequently, 27 million Americans annually

chemotherapy to treat the cancer that was caused by the virus. If you could prevent these scenarios from happening, would you? Governor Rick Perry sought to do just that, when he made Texas the first state to mandate that young girls receive the Gardasil vaccine, the leading vaccine that prevents against certain strains of HPV. Governor Perry’s new mandate will protect people from a painful, and sometimes fatal, disease. While the decision has gone under fire from people

common types.15 Fortunately, there are two vaccinations that have been found to prevent cervical cancer. Gardasil® prevents four types of HPV: 6, 11, 16 and 18, while Cervarix® prevents two types: 16 and 18. These vaccinations target the two most common types of HPV (16 and 18) that are responsible for 70% of the invasive cervical cancer cases.3 These vaccines also provide some cross

cervical cancer, making it the third most common cancer in New Zealand for women aged 25-44. At least 50 women will die from this cancer annually. In 2006 Gardasil, a vaccination produced by Merck, was approved by the FDA (Food and Drug Administration), as a vaccine for females aged 9-26, to combat HPV strains known to lead to cancer. In 2008 the Gardasil immunization was added to New Zealand’s immunization schedule and in 2009, this vaccination began to be administered in schools. Not only is New Zealand